CD8A and neoplasm: It also improves blood flow and tumor perfusion, reducing hypoxia, increasing antigen presentation by dendritic cells and M1 TAMs, and promoting the activation of CD8+ lymphocytes and the reprogramming of M2 TAMs towards M1 phenotype [11,14,36,55].